Publication Name	World Journal of Clinical Oncology
Manuscript ID	8310
Country	Spain

Received	2013-12-25 09:23
Peer-Review Started	2013-12-25 16:08
To Make the First Decision	2014-01-08 13:49
Return for Revision	2014-01-16 15:26
Revised	2014-01-22 03:07
Second Decision	2014-04-16 17:13
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-04-16 17:24
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-05-07 14:44
Publish the Manuscript Online	2014-05-12 18:06

ISSN	2218-4333 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	Different strategies of treatment for uterine cervical carcinoma stage ⅠB2-ⅡB
Manuscript Source	Invited Manuscript
All Author List	Lucas Minig, María Guadalupe Patrono, Nuria Romero, Juan Francisco Rodríguez Moreno and Jesús Garcia-Donas
Funding Agency and Grant Number
Corresponding Author	There is no currenty demonstrated the best option of treatment for women with locally advanced cervical cancer Federation of Gynecology and Obstetrics stage  IB2-IIB. This article describe the evidence as well as the advantages and disadvantages of the main strategies of treatment.
Key Words	Locally advanced cervical cancer; Federation of Gynecology and Obstetrics stage IB2-IIB; Radiotherapy; Neoajuvant chemotherapy; Radical hysterectomy
Core Tip	The standard of care for women with locally advanced cercical cancer (Stage IB2-IIB) is not well determined yet. Concurrent chemoradiation is the standard of care in United Sated and Canada: and neoadjuvant chemotherapy followed by radical surgery is the first line of treatment in some institutions of Europe, Asia and Latin America. Until today, there is no evidence of which strategy is better over the other. This article provides the evidence as well as the advantages and disadvantages of the main strategies of treatment for women affected by uterine cervical cancer stage IB2-IIB
Publish Date	2014-05-12 18:06
Citation	Minig L, Patrono MG, Romero N, Rodríguez Moreno JF, Garcia- Donas J. Different strategies of treatment for uterine cervical carcinoma stage ⅠB2-ⅡB. World J Clin Oncol 2014; 5(2): 86-92
URL	http://www.wjgnet.com/2218-4333/full/v5/i2/86.htm
DOI	http://dx.doi.org/10.5306/wjco.v5.i2.86

Full Article (PDF)	WJCO-5-86.pdf
Full Article (Word)	WJCO-5-86.doc
Manuscript File	8310-Review.docx
Answering Reviewers	8310-Answering reviewers.pdf
Copyright License Agreement	8310-Copyright assignment.pdf
Peer-review Report	8310-Peer reviews.pdf
Scientific Editor Work List	8310-Scientific editor work list.doc